GPS Wealth Strategies Group’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-110
Closed -$13K 351
2022
Q3
$13K Hold
110
﹤0.01% 706
2022
Q2
$15K Hold
110
﹤0.01% 681
2022
Q1
$15K Hold
110
﹤0.01% 641
2021
Q4
$19K Sell
110
-175
-61% -$26.6K ﹤0.01% 598
2021
Q3
$41K Hold
285
0.01% 424
2021
Q2
$38K Hold
285
0.01% 463
2021
Q1
$36K Buy
+285
New +$35.1K 0.01% 443

Other funds holding DGX

GPS Wealth Strategies Group's DGX Position: Q4 2022 in Review

GPS Wealth Strategies Group sold out of Quest Diagnostics (DGX) in Q4 2022, closing a stake of 110 shares — an estimated $13K sold.

GPS Wealth Strategies Group first reported a position in DGX in Q1 2021 and held it in 7 quarters. The position peaked at $41K in Q3 2021. 879 funds tracked by Wall St. Rank hold DGX as of Q4 2022.

  • GPS Wealth Strategies Group reported no remaining Quest Diagnostics position as of Q4 2022 after selling out during the quarter.
  • GPS Wealth Strategies Group sold 110 Quest Diagnostics shares in Q4 2022, an estimated $13K.
  • GPS Wealth Strategies Group first reported a position in Quest Diagnostics in Q1 2021 and held it in 7 quarters.
  • GPS Wealth Strategies Group's Quest Diagnostics position peaked at $41K in Q3 2021.
  • 879 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2022.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2022, filed 27 Jan 2023.